The Vanguard Group 13D and 13G filings for Elevation Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-01-30 9:33 pm Sale |
2024-12-31 | 13G | Elevation Oncology, Inc. ELEV |
The Vanguard Group | 2,610,045 4.410% |
-461,535![]() (-15.03%) |
Filing |
2024-11-12 2:22 pm Unchanged |
2024-09-30 | 13G | Elevation Oncology, Inc. ELEV |
The Vanguard Group | 3,071,580 5.190% |
0 (Unchanged) |
Filing |
2024-11-04 11:49 am Purchase |
2024-09-30 | 13G | Elevation Oncology, Inc. ELEV |
The Vanguard Group | 3,071,580 5.190% |
3,071,580![]() (New Position) |
Filing |